CHICAGO–(BUSINESS WIRE)–#biomarker—Nucleai, a leading provider of artificial intelligence (AI) solutions for pathology and spatial biology,…
The clinical trial of the personalized cancer vaccine EVX-01 met its primary endpoints of safety…
Additional long-term data from the TRiMM-2 study in patients receiving talquetamab and DARZALEX® (daratumumab) subcutaneous (SC)…
– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data…
BEERSE, BELGIUM, June 03, 2023 (GLOBE NEWSWIRE) — The Janssen Pharmaceutical Companies of Johnson &…
– Data presented at ASCO annual meeting demonstrate 55% Disease Control Rate (DCR) in heavily…
Updated data from ongoing IGNYTE anti-PD1 failed melanoma cohort shows RP1 combined with nivolumab continues…
– Met Primary Endpoint with 63.4% Median Reduction in LDL-C (p<0.0001) – – 87.1% of Patients Treated…
Enactment of Federal Legislation to Raise U.S. Debt Limit Ratifies and Expedites Approvals, Declares Project…
LOS ANGELES–(BUSINESS WIRE)–$S—Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Findings in over 3,000 subjects demonstrate highly sensitive and specific detection of multiple cancers at…
Data update from AFM24-101 phase 1/2 monotherapy study includes 15 patients from the EGFR mutant…
Long Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials Demonstrate Potential of Allogeneic CD19…
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome…
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated…
Early on-treatment ctDNA reduction in stable disease patients treated with KIMMTRAK was associated with longer…
NEW YORK–(BUSINESS WIRE)–Massive Bio, a leader in leveraging artificial intelligence and concierge services to empower…
CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, June 02, 2023 (GLOBE NEWSWIRE) — Atlas Global Brands Inc….
Changes in line with Vision 2025 strategy David Hayes named Chief Financial Officer IRVINE, Calif.–(BUSINESS…
Changes in line with Vision 2025 strategy David Hayes named Chief Financial Officer IRVINE, Calif.–(BUSINESS…